Oxford BioDynamics (LON:OBD) Trading Down 19.8% – Here’s What Happened

Oxford BioDynamics Plc (LON:OBD) shares dropped 19.8% during trading on Friday . The stock traded as low as GBX 0.12 and last traded at GBX 0.14. Approximately 29,025,111 shares were traded during mid-day trading, an increase of 102% from the average daily volume of 14,404,227 shares. The stock had previously closed at GBX 0.17.

Oxford BioDynamics Price Performance

The business’s 50 day moving average is GBX 0.19 and its two-hundred day moving average is GBX 0.23. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The firm has a market capitalization of £5.92 million, a PE ratio of -0.17 and a beta of 0.42.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.